HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide.

AuthorsS L Venance, K Jurkat-Rott, F Lehmann-Horn, R Tawil
JournalNeurology (Neurology) Vol. 63 Issue 10 Pg. 1977 (Nov 23 2004) ISSN: 1526-632X [Electronic] United States
PMID15557532 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Carbonic Anhydrase Inhibitors
  • NAV1.4 Voltage-Gated Sodium Channel
  • SCN4A protein, human
  • Sodium Channels
  • Acetazolamide
  • Potassium
Topics
  • Acetazolamide (therapeutic use)
  • Adult
  • Carbonic Anhydrase Inhibitors (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Hypokalemic Periodic Paralysis (drug therapy, genetics)
  • Male
  • NAV1.4 Voltage-Gated Sodium Channel
  • Palliative Care
  • Physical Exertion
  • Potassium (therapeutic use)
  • Sodium Channels (deficiency, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: